Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARDN.L Regulatory News (ARDN)

  • There is currently no data for ARDN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Changes

23 Oct 2012 11:00

RNS Number : 3090P
Arden Partners plc
23 October 2012
 



October 23rd, 2012

 

 

Arden Partners plc ("Arden" or the "Company")

 

Board Changes

 

Arden Partners plc, the AIM listed small/mid cap institutional broker today announces a number of changes to its Board and Executive Management responsibilities which will provide a more focussed business structure. The changes reduce the size of the Board to a level which is perhaps more relevant to a company of this size.

 

Non-Executive Chairman, Lord Flight, of Worcester, will shortly be stepping down from the Board in order to devote more time to other business and political interests. It is expected that this departure will be effective from 31st December 2012,

 

Also with effect from 31st, December 2012, following an appropriate handover process, Trevor Norris, Group Finance Director and Company Secretary, will also be retiring from the Board and leaving the Company with a view to expanding his other business ventures.

 

As a consequence of these departures the following changes to the roles of other Directors are being made, with effect from 1st January 2013.

 

·; Peter Moon, Non-Executive Director will become Non-Executive Chairman (designate). Peter will also serve as Chairman of the Remuneration and Nominations Committees.

 

·; Mark Ansell remains the Senior Independent Non-Executive Director and continues in this role and in his position as Chairman of the Audit Committee.

 

·; Jonathan Keeling, Chief Executive Officer, will become Executive Deputy Chairman, with specific responsibility for developing Arden's Global reach.

 

·; James Reed-Daunter, Executive Director, is to become Chief Executive Officer (designate).

 

·; Steve Wassell continues as Chief Operating Officer (COO) and adds the role of Company Secretary.

 

·; Financial reporting to the Board becomes the responsibility of Arden's current Financial Controller, who will report to the COO on a day to day basis.

 

It is anticipated that the revised board structure will enable Jonathan to spend more time on his Global responsibilities leaving James to take control of managing the business.

 

 

Jonathan Keeling commented:

 

"I would like to thank Lord Flight for having chaired the business through what has been a difficult period for our industry. In stepping down he has played an active and major part in the restructuring of the business and the Board and we very much appreciate his contribution in this regard.

 

I would also like to thank Trevor Norris for his long and loyal service to Arden Partners since its inception.

 

Lord Flight commented:

 

"I have enjoyed working with Jonathan Keeling who has done a great job in establishing and sustaining Arden's Indian corporate business. I believe there is major potential to expand Arden's international business and it must be right for Jonathan to be freed up to concentrate on this.

 

I think James Reed-Daunter is the right man to take over as Chief Executive to manage both the Arden team and the cost base.

 

I congratulate Arden for remaining in strong shape in a difficult business environment and wish the Company every success going forward."

 

The above appointments, where appropriate, are subject to FSA approval.

 

The Directors are mindful of their obligations with regard to maintaining good and progressive corporate governance.

 

Further info:

 

James Reed-Daunter

Jonathan Keeling

Arden Partners

020 7614 5900

Sam Fuller

Altium

020 7484 4037

Mark Edwards

Buchanan Communications

020 7466 5109

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAKMMZGLFLGZZG
Date   Source Headline
11th Mar 202112:30 pmRNSDirector/PDMR Shareholding
11th Mar 202110:55 amRNSHolding(s) in Company
3rd Mar 20218:53 amRNSShare Purchase By Employee Benefit Trust
2nd Mar 20214:11 pmRNSGrant of Options
2nd Mar 202110:21 amRNSShare Purchase by Employee Benefit Trust
18th Feb 20213:38 pmRNSPublication of Annual Report and Notice of AGM
17th Feb 202110:55 amRNSShare Purchase By Employee Benefit Trust
16th Feb 20217:00 amRNSAudited Results For The Year Ended 31 October 2020
11th Feb 20211:17 pmRNSDirector/PDMR Shareholding
12th Jan 20212:27 pmRNSDirector/PDMR Shareholding
11th Dec 202012:54 pmRNSDirector/PDMR Shareholding
11th Nov 20203:13 pmRNSTransaction in Own Shares
27th Oct 20209:43 amRNSShare Purchase by Employee Benefit Trust
13th Oct 202010:39 amRNSDirector/PDMR Shareholding
8th Oct 20209:43 amRNSShare Purchase by Employee Benefit Trust
17th Sep 202011:25 amRNSShare Purchase by Employee Benefit Trust
11th Sep 20208:43 amRNSDirector/PDMR Shareholding
7th Sep 202011:04 amRNSShare Purchase by Employee Benefit Trust
4th Sep 202011:57 amRNSShare Purchase by Employee Benefit Trust
11th Aug 20203:43 pmRNSDirector/PDMR Shareholding
11th Aug 20209:15 amRNSShare Purchase by Employee Benefit Trust
29th Jul 20209:05 amRNSShare Purchase by EBT and Holdings in Company
27th Jul 20207:00 amRNSInterim Results - Six Months Ended 30th April 2020
14th Jul 20209:56 amRNSDirector/PDMR Shareholding
9th Jul 20208:38 amRNSHolding(s) in Company
26th Jun 20209:08 amRNSShare Purchase By Employee Benefit Trust
11th Jun 20203:31 pmRNSDirector/PDMR Shareholding
11th Jun 20209:02 amRNSShare Purchase by Employee Benefit Trust
26th May 202011:00 amRNSHolding(s) in Company
26th May 202011:00 amRNSHolding(s) in Company
26th May 202010:58 amRNSDirector/PDMR Shareholding
26th May 20207:00 amRNSEmployee Incentivisation
21st May 20209:50 amRNSShare Purchase by Employee Benefit Trust
19th May 20207:00 amRNSHolding(s) in Company
12th May 20201:36 pmRNSDirector/PDMR Shareholding
1st May 20207:00 amRNSTrading Update
24th Apr 202010:28 amRNSHolding(s) in Company
15th Apr 202012:24 pmRNSDirector/PDMR Shareholding
8th Apr 20208:43 amRNSHolding(s) in Company
30th Mar 202011:55 amRNSForm 8.5 (EPT/NON-RI)
25th Mar 20202:39 pmRNSResult of AGM
20th Mar 20207:00 amRNSStatement Re AGM and Change of Venue
19th Mar 20207:00 amRNSStatement Regarding Share Price Movement
11th Mar 20201:19 pmRNSDirector/PDMR Shareholding
18th Feb 20202:26 pmRNSPublication of Annual Report and Notice of AGM
11th Feb 20202:10 pmRNSDirector/PDMR Shareholding
3rd Feb 20207:00 amRNSPreliminary Results - Year Ended 31 October 2019
13th Jan 20201:51 pmRNSDirector/PDMR Shareholding
2nd Jan 202011:55 amRNSForm 8.5 (EPT/NON-RI)
31st Dec 201911:00 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.